SocraTec R&D

Executive Summary

SocraTec R&D is a German private company founded in 2003, specializing in early-phase clinical development (Phase I and II) with a focus on drug delivery and small molecules. Based in Ober-Mörlen, the company operates a modular research facility designed for high flexibility and adaptability to various study designs. While detailed financial and pipeline information is limited, the company's core competency lies in providing customized clinical trial services to pharmaceutical and biotech partners. Its location in the heart of Erfurt, Thuringia, positions it within a European life sciences hub, potentially enabling collaboration with regional and international sponsors.

Upcoming Catalysts (preview)

• Q3 2026New Clinical Trial Agreement with a Major Sponsor60% success
• Q4 2026Expansion or Upgrade of Modular Facility50% success
• TBDPartnership or Joint Venture in Drug Delivery Technologies30% success